Objective: To evaluate galactography and cytology in women with nipple disc
harge without clinical or mammographic evidence of cancer.
Methods: During a 12.5-year period, 384 women (15-85 years, mean age 47.5 /- 14 years) were referred for galactography and smear cytology for recent
onset of spontaneous, non-milky nipple discharge. Patients with clinical or
mammographic evidence of tumor underwent excisional biopsy directly. Among
314 galactograms, 189 [60.2%; 95% confidence interval (CI) 54.5%, 65.6%] b
iopsies were recommended. A further 11 patients were scheduled for biopsy b
ecause of mammography or cytology.
Results: Sixteen of 182 biopsied patients had malignancies (8.8%; CI 5.3%,
14.1%). Combined rate of papillomas, papillomatous proliferation, and malig
nant tumors was 59.9% (109 of 182; CI 52.4%, 67.0%). Biopsy was malignant i
n three of 56 women (5%) with nonhemorrhagic discharge and in 13 of 97(13%)
with hemorrhagic discharge (P = .26). Exfoliative cytology revealed 11 fal
se-negatives, four false-positives, five true-positives, and 153 true-negat
ives (sensitivity 31.2%, CI 11%, 58%; specificity 97.4%, CI 93%, 99%). In t
en of 158 patients (6.3%) with suspicious galactography, cancer was found b
y biopsy. Sensitivity of galactography for malignancy was 83% (CI 51.6%, 97
.9%) and specificity was 41% (CI 35.2%, 46.5%). Galactographic sensitivity
for any (benign or malignant) neoplasm was 94% (93 of 99; CI 87%, 98%) and
specificity was 55% (119 of 215; CI 48%, 62%). Half of the cancers were det
ected exclusively by galactography.
Conclusion: Cytology is helpful when positive and galactography localizes t
he source of discharge. Biopsy is indicated when palpation, mammography, cy
tology, or galactography is suspicious. (C) 2001 by The American College of
Obstetricians and Gynecologists.